Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:37 AM
Ignite Modification Date:
2025-12-25 @ 3:37 AM
NCT ID:
NCT01060202
Eligibility Criteria:
Inclusion Criteria:
* Symptomatic multiple myeloma patient
* ECOG score less than 3
* Patient is not a candidate for stem cell transplantation
* Previous treatment duration is less than 6 months
* Previous treatment response is less than partial response (PR)
* Willing and able to complete the questionnaire
* Patients (or their legally acceptable representatives) must have signed an informed consent document indicating that they understand the purpose of and procedures required for the study and are willing to participate in the study
Exclusion Criteria:
* Known hypersensitivity to bortezomib
* Acute severe infection requiring antibiotics therapy
* Pre-existing peripheral neuropathy greater than or equal to grade 2
* Uncontrolled or severe cardiovascular disease
* Pregnancy or breastfeeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT01060202
Study Brief:
Protocol Section:
NCT01060202